MedChemExpress ATWLPPR Peptide TFA
66,15 € HT
MedChemExpress ATWLPPR Peptide TFA, a heptapeptide, acts as a selective neuropilin-1 inhibitor, inhibits VEGF165 binding to NRP-1, used in the research of angiogenesis. ATWLPPR Peptide TFA has potential in reducing the early retinal damage caused by diabetes.
- Pureté
- 99.34%
- Contenu et stockage
- Sealed storage, away from moisture and light∣Powder -80°C 2 years, -20°C 1 year∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture and light)
- À utiliser avec (application)
- COVID-19-immunoregulation
- Poids moléculaire
- 954.0 g/mol
- Type de produit
- Reference compound
- Marque
- MedChemExpress
